Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue
K-Number: K250482 · 2025-05-08
ApplicantFissiontech, LLC
Decision Date2025-05-08
Product CodeLRK
Advisory CommitteeDE
DecisionSubstantially Equivalent
Device Summary
Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue is a medical device manufactured by Fissiontech, LLC. It received FDA 510(k) clearance on 2025-05-08 under approval number K250482. The device is classified under product code LRK. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue?
Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue is a medical device that received FDA 510(k) clearance on 2025-05-08. It is manufactured by Fissiontech, LLC. The 510(k) number is K250482.
When was Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue approved by the FDA?
Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue received FDA 510(k) clearance on 2025-05-08, under approval number K250482.
What company makes Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue?
Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue is manufactured by Fissiontech, LLC.
What is the FDA product code for Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue?
The FDA product code for Advanced Anti Snoring Device 4.0 Clear/ Advanced Anti Snoring Device 4.0 Blue is LRK.
Related Clinical Trials
NCT07613931
Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
NOT_YET_RECRUITING
NCT07613658
3D-Printed Versus Band-and-Loop Versus Denovo Space Maintainers in Primary Dentition.
NOT_YET_RECRUITING
NCT07544654
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
NOT_YET_RECRUITING
NCT07605182
Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal Age
NOT_YET_RECRUITING
NCT07595835
CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer
RECRUITING
NCT07601828
Oxygen Delivery Index (ODIN) Study
NOT_YET_RECRUITING
Related PubMed Literature
PMID: 42173550
Towards a feature-based regulatory benchmark for user-centred SaMD design in cancer care.
BMJ health & care informatics (2026)
PMID: 41832928
Artificial intelligence as medical device in radiology in 2025: the regulatory scenario in the EU, USA, and China.
European radiology (2026)
PMID: 41815749
The history of state preemption and medical device regulation: lessons for artificial intelligence oversight.
Health affairs scholar (2026)
PMID: 41533265
Modernizing Medical Software Regulation in Bangladesh: A Roadmap for Risk-Based SaMD Oversight.
Journal of medical systems (2026)
Other Devices by Fissiontech, LLC
Related Devices (Code: LRK)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.